QR kȏd

Phosphodiesterase Inhibitors: Present and Future

Phosphodiesterase (PDE) inhibitors act on specific phosphodiesterase enzymes (fundamentally 3, 4 and 5), which are characterized by their expression in different organs. Currently, their use is approved for the treatment of chronic obstructive pulmonary disease (COPD), erectile dysfunction, pulmonar...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autor: José L. Izquierdo-Alonso
Format: Artigo
Jezik:Inglês
Izdano: Publicaciones Permanyer 2023-01-01
Serija:Barcelona Respiratory Network Reviews
Teme:
Online pristup:https://www.brnreviews.com/frame_esp.php?id=225
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!